Polynovo Limited (ASX: PNV) - ETF Exposure
Current share price for PNV : $0.935 0.015 (1.63%)+
Polynovo Limited (PNV) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is engaged in the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb.
PNV General Information +
| ASX Code | PNV |
| Website | http://polynovo.com |
| Industry/Sector | Health Care Supplies |
| Market Cap ($M) | 645 |
| PNV Share Price | $0.935 |
| Day High | $0.950 |
| Day Low | $0.915 |
| Last Close | $0.920 |
| PNV Share Price Movement | $0.02 ( 1.63% ) |
Prices as at 16:40, 9 Oct 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Already own an Australian ETF? You may already have meaningful exposure to PNV
Polynovo Limited (PNV) is held across 11 ETFs spanning strategies that include health care supplies exposure . Its weighting in those funds means performance can have an outsized influence - when PNV moves, funds like IMPQ, SSO, ISO, VETH and VAS that hold it can move with it.
For more concentrated exposure, ETFs such as IMPQ (eInvest Better Future (Managed Fund)) allocate about 3.4% to PNV , while the average exposure across all 11 ETFs that hold it is around 0.4% .
Top ETF holdings
- eInvest Better Future (Managed Fund) (IMPQ) ~ 3.4%
- State Street SPDR S&P/ASX Small Ordinaries ETF (SSO) ~ 0.2%
- iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) ~ 0.2%
- Vanguard Ethically Conscious Australian Shares ETF (VETH) ~ 0%
- Vanguard Australian Shares Index ETF (VAS) ~ 0%
Last updated: ETF data and holdings as at 9 October 2026
Own PNV directly or through an ETF?
How does holding Polynovo Limited (PNV) shares directly compare to ETFs that include it?
|
PNV Direct
|
IMPQ
ASX |
SSO
ASX |
ISO
ASX |
VETH
ASX |
VAS
ASX |
|
|---|---|---|---|---|---|---|
| Holdings | 1 company | 41 holdings | 219 holdings | 218 holdings | 239 holdings | 331 holdings |
| PNV Weight | 100% | 3.4% | 0.2% | 0.2% | 0% | 0% |
| Diversification | Single Stock | Broad | Broad | Broad | Broad | Broad |
| Annual Cost | Brokerage only | - | 0.5% p.a. | 0.55% p.a. | 0.16% p.a. | 0.07% p.a. |
| Approx. Yield | 0% | - | 9.52% | 4.49% | 2.93% | 3.19% |
| Star Ratings | - | Not Rated |  |
|
|
|
Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not PNV's direct yield. Annual cost uses each ETF's MER.
PNV Exposure on $10,000 investment
How a $10,000 investment in Polynovo Limited (PNV) one week ago compares with ETFs that hold it.
| Security | Investment type | Current price | 7-day price movement | Dollar change | Value today |
|---|---|---|---|---|---|
| Polynovo Limited (PNV) | Direct share | $0.935 | 3.31% | +$331 | $10,331 |
| eInvest Better Future (Managed Fund) (IMPQ) | - | $3.980 | 0% | $0 | $10,000 |
| State Street SPDR S&P/ASX Small Ordinaries ETF (SSO) | Equity - Australia Small/Mid Cap | $14.090 | -1.33% | -$133 | $9,867 |
| iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) | Equity - Australia Small/Mid Cap | $4.870 | -1.81% | -$181 | $9,819 |
| Vanguard Ethically Conscious Australian Shares ETF (VETH) | Equity - Australia Strategy | $65.900 | 0.20% | +$20 | $10,020 |
| Vanguard Australian Shares Index ETF (VAS) | Equity - Australia | $107.920 | 0.37% | +$37 | $10,037 |
Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.
Polynovo Limited (PNV) ETFs
11 ETFs hold Polynovo Limited (PNV).
| ETF | PNV Weight | MER | Yield |
|---|---|---|---|
| eInvest Better Future (Managed Fund) (IMPQ) | 3.4% | - | - |
| State Street SPDR S&P/ASX Small Ordinaries ETF (SSO) | 0.2% | 0.5% | 9.52% |
| iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) | 0.2% | 0.55% | 4.49% |
| Vanguard Ethically Conscious Australian Shares ETF (VETH) | 0% | 0.16% | 2.93% |
| Vanguard Australian Shares Index ETF (VAS) | 0% | 0.07% | 3.19% |
| Global X Australia 300 ETF (A300) | 0% | 0.03% | 3.08% |
| Dimensional Australian Core Equity (Managed Fund) (DACE) | 0% | 0.28% | 3.18% |
Polynovo Limited (PNV) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Polynovo Limited (PNV) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Polynovo Limited (PNV) price-sensitive announcements
PNV - FY26 Full Year Results Investor Presentation
PolyNovo Limited's FY26 Full Year Results presentation highlights a strong financial perfo
Polynovo Limited (PNV)
26 Aug 2026 | 7:56 AM
26 Aug 2026 | 7:56 AM
PNV - ASX Announcement - FY26 Full Year Results
PolyNovo Limited, a medical technology company focused on wound care solutions, announced
Polynovo Limited (PNV)
26 Aug 2026 | 7:56 AM
26 Aug 2026 | 7:56 AM
PNV - FY26 Full Year Results and Appendix 4E
PolyNovo Limited reported its financial results for the fiscal year ending 30 June 2026, h
Polynovo Limited (PNV)
26 Aug 2026 | 7:55 AM
26 Aug 2026 | 7:55 AM
PNV - PolyNovo FY26 Trading Update
PolyNovo Limited reported a strong financial performance for FY26, with a notable 16.1% in
Polynovo Limited (PNV)
23 Jul 2026 | 8:30 AM
23 Jul 2026 | 8:30 AM
Polynovo Limited (PNV) Recent ASX Announcements
PNV Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2028F | C2 | $2.00 | 100.00% | 46.80 | 0.00 | 0.00% | 0.0% |
| 2027F | C2 | $1.00 | -41.90% | 93.50 | 0.00 | 0.00% | 0.0% |
| 2026A | $12.06 | $1.70 | -9.00% | 67.10 | 0.00 | 0.00% | 0.0% |
PNV Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 A | 2027 F | 2028 F | 2026 A | 2027 F | 2028 F | 2026 A | 2027 F | 2028 F | ||
| Ansell Limited (ANN) | $6,328M | 0.1231 | -0.0858 | 0.1003 | 20.9885 | 22.9575 | 20.8651 | 2.20% | 1.83% | 2.03% |
| Nanosonics Limited (NAN) | $838M | -0.1375 | -0.3501 | 0.6933 | 48.5269 | 74.6667 | 44.0945 | 0.00% | 0.00% | 0.00% |
| Polynovo Limited (PNV) | $636M | -0.0899 | -0.4186 | 1.0000 | 53.4884 | 92.0000 | 46.0000 | 0.00% | 0.00% | 0.00% |
PNV Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.58 | 61.50 | 7.12 | 7.85 |
| Market | 0.37 | 14.00 | 1.06 | 0.74 |
| Sector | 0.71 | 21.30 | 2.12 | 2.46 |
PNV Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Andrew Price | Non-Executive Director | 18 Sep 2026 |
| Dr Robyn Elliott | Non-Executive Director | 28 Oct 2019 |
| Mr Andrew Stuart Lumsden | Non-Executive Director | 4 Jun 2021 |
| Ms Christine Emmanuel-Donnelly | Non-Executive Director | 13 May 2020 |
| Dr Charmaine Hilary Gittleson | Non-Executive Director | 1 Apr 2026 |
| Mr Robert Douglas | Non-Executive Director | 14 Oct 2025 |
| Mr Dean Phizacklea | Non-Executive Director | 18 Sep 2026 |
| Mr Leon Hoare | Non-Executive Director, Non-Executive Chairman | 27 Jan 2016 |
Polynovo Limited (PNV) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 12 Mar 2026 | DOUGLAS, Robert | Buy | Indirect Shares | 151,000 | $0.930 | $140,430.000 |
| 25 Feb 2026 | HOARE, Leon | Buy | Indirect Shares | 30,000 | $0.936 | $28,071.920 |
| 24 Feb 2026 | LUMSDEN, Andrew | Buy | Indirect Shares | 100,000 | $0.914 | $91,364.160 |
See all changes in directors' interest & trades for Polynovo Limited (PNV) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
PNV Management
| Name | Position |
|---|---|
| Swami Raote | Chief Executive Officer |
| Bruce Peatey | Chief Executive Officer |
| Jan-Marcel Gielen | Chief Financial Officer |
| Jan-Marcel Gielen | Company Secretary |
| Amy Demediuk | General Counsel ,Company Secretary |
PNV Calendar of Events
| Date | Event |
|---|---|
| 14 September 2027 | Report (Annual) |
| 25 August 2027 | Report (Annual) |
| 25 August 2027 | Report (Prelim) |
| 19 February 2027 | Report (Interim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
